The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar complaints reported from this lot.Based on available information, the reported failure to advance (low transseptal puncture) was due to challenging patient anatomy (abnormal bifurcation).The cause of the reported heart failure/congestive heart failure, and the reported hypotension, could not be determined.The reported patient effects of heart failure and hypotension, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported medication required was a result of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
This is filed to report heart failure and intervention with medication.It was reported that a patient presented with grade 4 mitral regurgitation (mr) and challenging anatomy for a mitraclip procedure.The inferior vena cava (ivc) had an abnormal bifurcation, and because of this the guidewire went to the tricuspid valve during several attempts to reach the septum.After over an hour the fossa ovalis was punctured.Transseptal access was difficult due to the inferior vena cava.It appeared the height was sufficient, but throughout the procedure it was noted the transseptal height was low (2-3cm).This presented challenges, as the clip could not gain enough height to be implanted on the valve.Troubleshooting to gain height was performed, but after 30 minutes the procedure was discontinued.The patient became unstable with heart failure (an ejection fraction between 10-15 percent) and hypotension.Adrenaline was administered to stabilize the patient.The procedure was discontinued without a mitraclip implanted.Per the physician, the mitraclip was responsible for the heart failure and hypotension.There were no adverse patient sequelae.No additional information was provided.
|